The global life sciences industry is transforming alongside the world’s increasing life expectancy, global population, and rapid advancements in technology and innovation. In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market […]
Donald Trump will be inaugurated on 20th January, beginning a four-year term that promises to usher in policies which will impact businesses in the United States and all over the world. Consultants and corporations alike should be aware of what to expect in the coming year – companies will need to successfully adapt to changes […]
As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. The echoes of past disruptions—whether through political rhetoric, policy agendas, or global crises—are familiar to those in the industry. But if history has taught us anything, it is […]